文献速递神经康复脊髓损伤康复

重复经颅磁刺激改善神经系统疾病患者下肢功能:随机假刺激对照试验的系统综述与荟萃分析

Efficacy of repetitive transcranial magnetic stimulation for improving lower limb function in individuals with neurological disorders: A systematic review and meta-analysis of randomized sham-controlled trials.
PubMed 文献 · J Rehabil Med · 2022-02-03

该系统综述与荟萃分析检索PubMed、CINAHL、Embase和Scopus数据库至2020年3月31日,纳入27项平行组随机对照试验,评估重复经颅磁刺激(rTMS)相较假刺激对神经系统疾病患者下肢功能的效果。结果显示rTMS对步态(效应量0.51,95%CI 0.29–0.74,p=0.003)、肌力(0.99,95%CI 0.40–1.58,p=0.001)以及卒中、帕金森病和脊髓损伤患者均有改善作用,但对移动能力和平衡未见效果。

要点

  • rTMS对步态与肌力有改善作用,对移动能力和平衡未见效果。
  • 卒中、帕金森病和脊髓损伤患者可从rTMS中获益。
  • 纳入研究存在中度的选择、失访和报告偏倚风险。

核心结论

  • 补充性rTMS可能促进以步行和肌力为重点的康复及下肢功能整体恢复,对卒中、帕金森病和脊髓损伤患者有益。
  • 现有证据仍需进一步研究以推广上述发现。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、CINAHL、Embase和Scopus数据库自建库至2020年3月31日,初检获文献1198篇。
  • 纳入平行组设计的随机临床试验,对象为神经系统疾病患者,含下肢功能结局指标,最终纳入27篇文献。
  • 两名研究者独立筛选文献、提取研究设计、人群特征、刺激方案和结局指标,并评估研究质量。

主要发现

  • rTMS对步态的效应量为0.51(95%CI 0.29–0.74,p=0.003),对肌力的效应量为0.99(95%CI 0.40–1.58,p=0.001)。
  • 按疾病分层:卒中0.20(95%CI 0.00–0.39,p=0.05),帕金森病1.01(95%CI 0.65–1.37,p=0.02),脊髓损伤0.50(95%CI 0.14–0.85,p=0.006)。
  • 对移动能力和平衡的结局未发现rTMS的效应。

关键数值与推荐

  • 纳入研究总体存在中度的选择偏倚、失访偏倚和报告偏倚风险。
  • 效应量比较对象为rTMS与假刺激,结局涵盖步态、肌力、移动能力和平衡。

临床怎么用

  • 对卒中、帕金森病和脊髓损伤患者,可将rTMS作为以步行和肌力为重点的康复辅助手段。
  • 不宜依据本证据期望rTMS改善移动能力或平衡,需结合其他康复措施。

局限性

  • 纳入研究存在中度的选择、失访和报告偏倚风险。
  • 作者指出需更多证据才能推广上述结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the efficacy of repetitive transcranial magnetic stimulation vs sham stimulation on improving lower-limb functional outcomes in individuals with neurological disorders. DATA SOURCES: PubMed, CINAHL, Embase and Scopus databases were searched from inception to 31 March 2020 to identify papers (n = 1,198). Two researchers independently reviewed studies for eligibility. Randomized clinical trials with parallel-group design, involving individuals with neurological disorders, including lower-limb functional outcome measures and published in scientific peer-reviewed journals were included. DATA EXTRACTION: Two researchers independently screened eligible papers (n = 27) for study design, clinical population characteristics, stimulation protocol and relevant outcome measures, and assessed study quality. DATA SYNTHESIS: Studies presented a moderate risk of selection, attrition and reporting bias. An overall effect of repetitive transcranial magnetic stimulation was found for outcomes: gait (effect size [95% confidence interval; 95% CI]: 0.51 [0.29; 0.74], p = 0.003) and muscle strength (0.99 [0.40; 1.58], p = 0.001) and disorders: stroke (0.20 [0.00; 0.39], p = 0.05), Parkinson's disease (1.01 [0.65; 1.37], p = 0.02) and spinal cord injury (0.50 [0.14; 0.85], p = 0.006), compared with sham. No effect was found for outcomes: mobility and balance. CONCLUSION: Supplementary repetitive transcranial magnetic stimulation may promote rehabilitation focused on ambulation and muscle strength and overall lower-limb functional recovery in individuals with stroke, Parkinson's disease and spinal cord injury. Further evidence is needed to extrapolate these findings.

来源:J Rehabil Med,查看原文。版权归原作者所有。

引用

  1. Krogh S, Jønsson AB, Aagaard P, et al. Efficacy of repetitive transcranial magnetic stimulation for improving lower limb function in individuals with neurological disorders: A systematic review and meta-analysis of randomized sham-controlled trials. J Rehabil Med. 2022. PMID: 34913062. doi:10.2340/jrm.v53.1097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。